REQUEST A DEMO
Total
USD $0.00
Search more companies

Pharex, S.R.O. (Slovakia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Pharex, S.R.O. Profile Updated: July 31, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Pharex, S.R.O. is an enterprise in Slovakia, with the main office in Bystricka. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was incorporated on April 09, 2008. It currently has a total number of 10 - 19 (2025) employees. From the latest financial highlights, Pharex, S.R.O. reported a net sales revenue increase of 20.58% in 2024. Over the same period, its total assets grew by 9.53%. In 2024, Pharex, S.R.O.’s net profit margin increased by 0.84%.

Headquarters
Zahradna, 557/3
Bystricka; Postal Code: 03804

Contact Details: Purchase the Pharex, S.R.O. report to view the information.

Website: http://www.pharex.sk/

Basic Information
Total Employees:
Purchase the Pharex, S.R.O. report to view the information.
Registered Capital:
Purchase the Pharex, S.R.O. report to view the information.
Financial Auditors:
Purchase the Pharex, S.R.O. report to view the information.
Incorporation Date:
April 09, 2008
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Pharex, S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
20.58%
Total operating revenue
20.14%
Operating profit (EBIT)
118.16%
EBITDA
81.07%
Net Profit (Loss) for the Period
110.9%
Total assets
9.53%
Total equity
15.96%
Operating Profit Margin (ROS)
1.26%
Net Profit Margin
0.84%
Return on Equity (ROE)
6.22%
Debt to Equity Ratio
-14.42%
Quick Ratio
-0.06%
Cash Ratio
0.08%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?